Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
February 09, 2024
From CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
From Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
December 04, 2023
Tickers
CBD
From Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
From Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
September 30, 2023
From CNBC.com News
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
August 03, 2023
From CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
From Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
July 20, 2023
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
From Benzinga
From CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
June 22, 2023
From Stock Gumshoe
From Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
From CNBC.com News
Medicare details plan to cover Alzheimer's treatments
June 01, 2023
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
From CNBC.com News
Getting Back to You on Anavex, Cassava, metformin and more
January 17, 2023
From Stock Gumshoe
Relevant Updates – December 2022
December 27, 2022
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
November 13, 2022
From CNBC.com News
Odd & Ends – October 2022
October 27, 2022
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.